LucasAnnex 9.1. Pathological overview of cardiac<strong>deaths</strong> including sudden adult/arrhythmic <strong>deaths</strong>yndrome (SADS)S Lucas (on behalf of the Centre for Maternal and Child Enquiries)St Thomas’ Hospital, London, UKCorrespondence: Dr Sebastian Lucas, St Thomas’ Hospital, 2nd Floor, North Wing, London SE1 7EH, UK. Email: sebastian.lucas@kcl.ac.ukCardiac <strong>deaths</strong>: pathology goodpractice points• Do the heart examination well, with full dissection ofthe coronary arteries, accurate weight of the heart,measurement of the ventricle thicknesses and carefulevaluation of the valves.• Correlate these data with the woman’s body weightand body mass index (BMI).• Do his<strong>to</strong>logy on a standard mid-horizontal slice ofheart muscle, <strong>to</strong> examine the right and left ventricles.• Look at the lung his<strong>to</strong>pathology for clues (e.g. pulmonaryhypertension).• Retain a blood sample in case cocaine and otherstimulant drug analysis is necessary.• Consider consulting a cardiac pathologist <strong>to</strong> gainadvice and support for the diagnosis.• If the diagnosis is going <strong>to</strong> be SADS, <strong>make</strong> sure allother reasonable cardiac diagnoses, as well as pregnancy-relateddiagnoses (such as amniotic fluidembolism), are excluded.• If SADS or a standard cardiomyopathy seems <strong>to</strong> bethe diagnosis, retain a sample of frozen spleen forpossible later genetic evaluation; the coroner will notbe expected <strong>to</strong> resource such investigations, but theNHS cardiac genetic clinics will.The main trends in cardiovascular pathology for this trienniumare the reduction in <strong>deaths</strong> associated with congenitalheart disease and the apparent rise in incidence ofSADS. This is better described as sudden arrhythmic <strong>deaths</strong>yndrome where unexpected and unpredicted cardiac arres<strong>to</strong>ccurs and it is discussed later.Cardiac pathology is what pathologists should do well, asit is the commonest scenario of death they encounter inroutine practice in the UK. Broadly, for coronary ischaemicheart disease, infective endocarditis, pulmonary hypertensionand congenital heart disease and for dissection ofaorta and other vessels, this was true in the <strong>maternal</strong> <strong>deaths</strong>reviewed this triennium. But it was not the case for difficult,non-obvious cases where acute cardiac failure was thescenario.Ischaemic heart diseaseIn the <strong>deaths</strong> examined, the usual patterns were seen ofcoronary artery atheroma, with or without acute thrombosis,and cardiac muscle damage, as either acute infarctionor chronic fibrotic ischaemic damage.Two women had different specific causes of coronaryartery occlusion. One had postpartum dissection of the leftanterior coronary artery causing myocardial infarction. It isremarkable that pregnancy is the major risk fac<strong>to</strong>r for suchdissection, albeit uncommon. It is presumed that thehormonal effect on arterial muscle <strong>to</strong>ne interacts on anin-built medial damage <strong>to</strong> cause it. From the practical perspective,pathologists should note that, without very closegross inspection, a dissection of a coronary artery can lookvery like an acute thrombosis; his<strong>to</strong>logy is useful here <strong>to</strong>confirm the process.The other woman was an adolescent who presented severalmonths after pregnancy with myocardial infarction.The aetiology was a rare au<strong>to</strong>immune disease (Kawasakidisease) with vasculitis of the coronary arteries and secondarystenosis and occlusion.Dissection of the aortaThe seven women who died from dissection of the aorta hadau<strong>to</strong>psies. Not surprisingly, most were well done, althoughthree reports had no height or weight (therefore no au<strong>to</strong>psyBMI was calculable). Although the gross pathology is selfevident,it is arguable whether his<strong>to</strong>pathology is required <strong>to</strong>116 ª <strong>2011</strong> Centre for Maternal and Child Enquiries (CMACE), BJOG 118 (Suppl. 1), 1–203
Annex 9.1: Pathological overview of cardiac <strong>deaths</strong>demonstrate the universal underlying aortic medial degeneration,but best practice is that it should be done. Moreimportant are co-pathologies relevant <strong>to</strong> the final dissection:two of the seven women had clinical pre-eclampsia, but therenal his<strong>to</strong>pathology (glomerular endotheliosis) was notdocumented <strong>to</strong> confirm this.None of the au<strong>to</strong>psy reports indicated whether geneticstudies of the fibrillin connective tissue gene were performed<strong>to</strong> demonstrate Marfan and Ehlers–Danlos syndromesif they had not already been evaluated. Essentially,in the age-range of pregnant women with dissection ofthe aorta, the pathogeneses are three-fold: inherited connectivetissue disease (e.g. Marfan); bicuspid aortic valveassociation (no fibrillin abnormality); and idiopathic. Bestpractice is <strong>to</strong> reserve spleen material in the freezer forlater DNA studies in all women with dissection of theaorta who have normal aortic valves. Importantly, it isnot for coroners’ and fiscals’ local authorities <strong>to</strong> fundsuch studies of potentially inheritable disease, it is for theNHS.Myocarditis and systemic lupuserythema<strong>to</strong>susIn the women for whom an au<strong>to</strong>psy <strong>to</strong>ok place, theactual aetiology of the myocarditis was not established.The causes include infection (usually enteroviral), drugallergy (e.g. antibiotics), named immunopathological conditionssuch as eosinophilic or giant cell myocarditis andsarcoidosis, and idiopathic. Inevitably, there is potentialfor overlap with peripartum cardiomyopathy, because insome of those cases there is a myocarditis, and the clinicaland pathological case definitions need <strong>to</strong> be closelyobserved. For myocarditis pathology, the Dallas criteriaapply: chronic inflammation (T-cell) in the myocardiumwith active destruction of myofibres, i.e. not just aninterstitial inflammation which can happen in many systemicinflamma<strong>to</strong>ry response states. A further difficultyfor pathologists is that the diagnosis of myocarditis isnot usually entertained until the fixed tissue his<strong>to</strong>pathologyis available, by which time the opportunity for takingunfixed heart and blood samples for virology andserodiagnosis is usually lost. Perhaps polymerase chainreaction technology will become more available for theretrospective diagnosis of viral myocarditis on fixed tissue.Peripartum and othercardiomyopathiesThis is a confusing area of cardiac pathology, where only afull cardiac examination pro<strong>to</strong>col, in conjunction with clinicaldata and family his<strong>to</strong>ry, will produce the correct diagnoses.Of the non-peripartum cardiomyopathies (PPCM),two were arrhythmogenic right ventricular cardiomyopathy(ARVCM). There is no known aetiological association ofARVCM, which is partly inherited, with pregnancy. Onewoman with myo<strong>to</strong>nic dystrophy died of heart failureimmediately postpartum; again only an experienced cardiacpathologist can really interpret the positive and negativefindings.Only six of the nine women who died from PPCM hadan au<strong>to</strong>psy. The case definition of PPCM is the onset ofleft ventricular sys<strong>to</strong>lic dysfunction and symp<strong>to</strong>ms of heartfailure during the last month of pregnancy or the first5 months postpartum. Sudden unexpected cardiac deathwithout previous heart failure is usually excluded. Thereare characteristic features pathologically—enlarged heart,dilated cardiomyopathy, irregular myofibres and fibrosis,variable T-cell infiltration, on his<strong>to</strong>pathology—and, critically,the absence of an alternative diagnosis. This is ahigh-stringency definition and for au<strong>to</strong>psy pathologists presentsthe problem of how far <strong>to</strong> investigate cases of acuteor chronic heart failure during and after pregnancy, <strong>to</strong> suppor<strong>to</strong>r exclude a clinical diagnosis of PPCM.In two au<strong>to</strong>psies, the pathologists referred the case <strong>to</strong> acardiac pathologist for opinion, and drug screens (mainlyfor stimulant drugs such as cocaine) were performed inanother two. One pathologist evidently had never heard ofthe entity and, following a good au<strong>to</strong>psy that clearly supportedPPCM, declared the ‘cause of the cardiac enlargementand failure’ <strong>to</strong> be ‘obscure’.The pathogenesis of PPCM is unknown, although a noninfectivepregnancy-associated immune activation myocarditiswith destruction of myofibres is the current leadinghypothesis. 1 The role of cardiac biopsy in diagnosing andmanaging possible PPCM is underdeveloped; none of thenine women in this triennium had one, although in mostcases there was the opportunity in hospitalised women <strong>to</strong>attempt it.Sudden adult/arrhythmic <strong>deaths</strong>yndromeTen women died of SADS during this triennium comparedwith three in the last Report. This is greater than in anyprevious Report. Six of them were obese, with bookingBMI ranging from 30 <strong>to</strong> 45.The case definition for SADS is a sudden unexpectedcardiac death (i.e. presumed fatal arrhythmia) where allother causes of sudden collapse are excluded, including adrug screen for stimulant drugs such as cocaine. Theseare exacting criteria. The UK Cardiac Pathology Network(www.cpn.org.uk) is encouraging fuller au<strong>to</strong>psy examinations(and reporting <strong>to</strong> a central database) and provides acomprehensive list of possible diagnoses for sudden car-ª <strong>2011</strong> Centre for Maternal and Child Enquiries (CMACE), BJOG 118 (Suppl. 1), 1–203 117
- Page 1:
Volume 118, Supplement 1, March 201
- Page 4 and 5:
AcknowledgementsSaving Mothers’ L
- Page 6 and 7:
AcknowledgementsAcknowledgementsCMA
- Page 8 and 9:
Forewordbeen written jointly by a m
- Page 10 and 11:
‘Top ten’ recommendationsServic
- Page 12 and 13:
‘Top ten’ recommendationscommun
- Page 14 and 15:
‘Top ten’ recommendationsof suc
- Page 16 and 17:
‘Top ten’ recommendationsMarch
- Page 18 and 19:
Oates et al.Back to basicsM Oates 1
- Page 20 and 21:
Oates et al.BreathlessnessBreathles
- Page 22 and 23:
Oates et al.appropriate pathway of
- Page 24 and 25:
LewisIntroduction: Aims, objectives
- Page 26 and 27:
LewisAn important limitation of ran
- Page 28 and 29:
Lewismaternal and public health-pol
- Page 30 and 31:
Lewisresult in a live birth at any
- Page 32 and 33:
LewisChapter 1: The women who died
- Page 34 and 35:
Lewiswho would not have been identi
- Page 36 and 37:
Lewis1098Rate per 100 000 materniti
- Page 38 and 39:
LewisTable 1.4. Numbers and rates o
- Page 40 and 41:
Lewis2.50Rate per 100 000 materniti
- Page 42 and 43:
LewisTable 1.9. Number of maternal
- Page 44 and 45:
LewisTable 1.12. Numbers and percen
- Page 46 and 47:
LewisThere were cases where a major
- Page 48 and 49:
LewisBox 1.5. Classifications of Bo
- Page 50 and 51:
LewisTable 1.20. Number and estimat
- Page 52 and 53:
LewisNew countries of the European
- Page 54 and 55:
LewisTable 1.23. Direct and Indirec
- Page 56 and 57:
LewisTable 1.26. Characteristics* o
- Page 58 and 59:
Lewis4 Lewis G (ed). The Confidenti
- Page 60 and 61:
DrifeTable 2.1. Direct deaths from
- Page 62 and 63:
Drifewomen who died in 2006-08 had
- Page 64 and 65:
Drifedelivery she became breathless
- Page 66 and 67:
DrifePathological overviewFourteen
- Page 68 and 69: NeilsonChapter 3: Pre-eclampsia and
- Page 70 and 71: Neilsontrue, and what might be the
- Page 72 and 73: NeilsonConclusionThe number of deat
- Page 74 and 75: NormanBackgroundIn the UK, major ob
- Page 76 and 77: Normanwhich there was catastrophic
- Page 78 and 79: Normanrecommendations made in succe
- Page 80 and 81: DawsonBox 5.1. The UK amniotic flui
- Page 82 and 83: Dawsontry despite an extensive sear
- Page 84 and 85: O’HerlihyTable 6.1. Numbers of Di
- Page 86 and 87: O’Herlihytoxic shock syndrome aft
- Page 88 and 89: HarperGroup A b-haemolytic streptoc
- Page 90 and 91: Harperthe 6-week postnatal period,
- Page 92 and 93: Harpera major intrapartum haemorrha
- Page 94 and 95: HarperBox 7.1. Signs and symptoms o
- Page 96 and 97: Harperwoman was given several litre
- Page 98 and 99: Harper2 Lamagni TL, Efstratiou A, D
- Page 100 and 101: LucasTable A7.1 Proposed new catego
- Page 102 and 103: Lucasthe same infection scenario as
- Page 104 and 105: McClure, CooperChapter 8: Anaesthes
- Page 106 and 107: McClure, Cooperaddress, but protoco
- Page 108 and 109: McClure, CooperPostpartum haemorrha
- Page 110 and 111: McClure, CooperWorkloadA number of
- Page 112 and 113: Nelson-PiercyTable 9.1. Indirect ma
- Page 114 and 115: Nelson-Piercynary arteries. In view
- Page 116 and 117: Nelson-Piercynormal left ventricle
- Page 120 and 121: Lucasdiac death that is non-ischaem
- Page 122 and 123: de Swiet et al.causes but are aggra
- Page 124 and 125: de Swiet et al.died of SUDEP before
- Page 126 and 127: de Swiet et al.for 6 weeks after de
- Page 128 and 129: de Swiet et al.mised. The obstetric
- Page 130 and 131: de Swiet et al.CancerPregnancy does
- Page 132 and 133: de Swiet et al.a thorough autopsy w
- Page 134 and 135: Oates, CantwellChapter 11: Deaths f
- Page 136 and 137: Oates, CantwellTable 11.1. Timing o
- Page 138 and 139: Oates, CantwellTable 11.5. Maternal
- Page 140 and 141: Oates, CantwellChild protection iss
- Page 142 and 143: Oates, CantwellAll women who are su
- Page 144 and 145: Oates, Cantwell4 Kendel RE, Chalmer
- Page 146 and 147: Lewismaternal mortality rates or ra
- Page 148 and 149: Annex 12.1. Domestic abuseAnnex 12.
- Page 150 and 151: Annex 12.1. Domestic abuseshe could
- Page 152 and 153: Garrod et al.supportive but challen
- Page 154 and 155: Garrod et al.• Culture and system
- Page 156 and 157: Garrod et al.the second stage and s
- Page 158 and 159: Garrod et al.through the still heal
- Page 160 and 161: ShakespeareChapter 14: General prac
- Page 162 and 163: Shakespeareemergency caesarean sect
- Page 164 and 165: ShakespeareCardiac diseaseDeaths fr
- Page 166 and 167: Shakespearereduce the risks to the
- Page 168 and 169:
ShakespeareManaging a maternal deat
- Page 170 and 171:
Hulbertin the ED was of a high qual
- Page 172 and 173:
HulbertPre-eclampsia/eclampsia: lea
- Page 174 and 175:
HulbertTransfersWhen the obstetric
- Page 176 and 177:
Clutton-Brocksimply the case that s
- Page 178 and 179:
Clutton-BrockDiagnosis of sepsisTak
- Page 180 and 181:
Clutton-Brockpulseless electrical a
- Page 182 and 183:
Clutton-BrockImprovement Scotland (
- Page 184 and 185:
Lucas, Millward-Sadler95 mmHg. This
- Page 186 and 187:
Lucas, Millward-Sadleran agreed mai
- Page 188 and 189:
Annex 17.1. The main clinico-tholog
- Page 190 and 191:
MillerAppendix 1: The method of Enq
- Page 192 and 193:
MillerDatanotificationNotificationR
- Page 194 and 195:
Knight• investigating different m
- Page 196 and 197:
Knightbaseline incidence against wh
- Page 198 and 199:
LennoxAppendix 2B: Summary of Scott
- Page 200 and 201:
LennoxEvidence of effective managem
- Page 202 and 203:
Appendix 3: Contributors to the Mat
- Page 204 and 205:
Appendix 3: Contributors to the Mat